# A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

> **NCT07139535** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Guangdong Raynovent Biotech Co., Ltd** · enrollment: 350 (estimated)

## Conditions studied

- T2DM

## Interventions

- **DRUG:** RAY1225
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT07139535
- **Lead sponsor:** Guangdong Raynovent Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-31
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07139535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07139535, "A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07139535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*